Covid-19 vaccine: Johnson & Johnson begins Phase-3 trial with 60k people

With the move, J&J becomes the tenth maker globally to conduct a Phase 3 trial against Covid-19, and the fourth in the US.

from Hindustan Times - world https://bit.ly/35YBJUN
https://ift.tt/2zbki14